Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-20

Clinical Trial Update: Vivity Outcomes in Patients With Early Stage Glaucoma

View source ↗

Summary

A completed clinical trial evaluating Vivity outcomes in patients with early-stage glaucoma; sponsor is Vance Thompson Vision.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vance Thompson Vision | Conditions: Glaucoma, Cataract | Status: COMPLETED